Darzalex Faspro

What is this medication? Darzalex Faspro is a prescription medication used to treat adults with multiple myeloma, which is a type of cancer that affects the plasma cells in the bone marrow. It is utilized both for patients who are newly diagnosed and for those whose cancer has returned or failed to respond to previous therapies. Additionally, this medication is approved for the treatment of light chain amyloidosis, a condition where abnormal proteins build up in various organs throughout the body, potentially causing damage.

The medication is a combination of two active ingredients: daratumumab and hyaluronidase-fihj. Daratumumab is a monoclonal antibody that targets a specific protein known as CD38 found on the surface of cancer cells, helping the immune system identify and destroy them. The inclusion of hyaluronidase allows the medicine to be administered as a subcutaneous injection under the skin, typically in the abdomen, which is much faster than traditional intravenous infusions. This delivery method helps shorten the time required for each treatment session.